Home › Carcinoma polmonare a piccole cellule › New Jersey
Studi clinici su Carcinoma polmonare a piccole cellule nello stato di New Jersey
17 studi su Carcinoma polmonare a piccole cellule cercano partecipanti presso sedi nello stato di New Jersey.
Città nello stato di New Jersey
Testo ufficiale dello studio (inglese)
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- John Theurer Cancer Center at Hackensack UMC, Hackensack
In reclutamentoFase 1
Età 19 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06586957Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
- MSK Basking Ridge, Basking Ridge
- MSK Monmouth, Middletown
- MSK Bergen., Montvale
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07476287A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Inspira Medical Center Mullica Hill /ID# 280574, Mullica Hill
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT07365241Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
- United Theranostics, Princeton
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07278479A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Hackensack University Medical Center, Hackensack
- Rutgers Cancer Institute of New Jersey, New Brunswick
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07488676BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
- Astera Cancer Care, East Brunswick
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 set 2026 · NCT07625644A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 1103), Hackensack
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 set 2026 · NCT06780137A Study of Armored CAR T Cells in People With Cancer
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 set 2026 · NCT07783477Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
- Morristown Medical Center, Morristown
- Rutgers Cancer Institute, New Brunswick
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 ago 2026 · NCT07057791A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
- Regional Cancer Care Associates, Belleville
- John Theurer Cancer Center at Hackensack UMC, Hackensack
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 26 ago 2026 · NCT06892548A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
- Hackensack University Medical Center, Hackensack
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT07488923A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 11 ago 2026 · NCT06807632A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Astera Cancer Care, East Brunswick
- Hackensack Meridian Health Jsumc, Neptune City
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 6 ago 2026 · NCT06203210A Study of LY4175408 in Participants With Advanced Cancer
- John Theurer Cancer Center At Hackensack UMC, Hackensack
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 giu 2026 · NCT07046923A Study of Hospital-at-Home for People Receiving Tarlatamab
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 12 giu 2026 · NCT06957314A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
- Memorial Sloan Kettering at Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 10 giu 2026 · NCT05419076VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Englewood Hospital and Medical Center (site 202), Englewood
- Summit Medical Group (site 205), Florham Park
- Atlantic Health System, Morristown Medical Center (site 124), Morristown
In reclutamentoFase 1/2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 11 dic 2025 · NCT03556228Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.